Amplifon SpAAMFPF 71 5-Year Yield-on-Cost % is 3.00 as of Jul. 01, 2026, which is 335% above its 10-year median of 0.69. GuruFocus rates AMFPF with a GF Score™ of 71/100 and a GF Value™ of $28.73 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 69 Medical Distribution companies, Amplifon SpA ranks worse than 55.07% on this metric.
Amplifon SpA's yield on cost for the quarter that ended in Mar. 2026 was 3.00.
The historical rank and industry rank for Amplifon SpA's 5-Year Yield-on-Cost % or its related term are showing as below:
AMFPF'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.33 Med: 0.69 Max: 3.46
Current: 3
During the past 13 years, Amplifon SpA's highest Yield on Cost was 3.46. The lowest was 0.33. And the median was 0.69.
AMFPF's 5-Year Yield-on-Cost % is ranked worse than 55.07% of 69
companies
in the Medical Distribution industry
Industry Median: 3.33
vs AMFPF: 3.00
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Amplifon SpA 5-Year Yield-on-Cost % Related Terms
AMFPF vs MCK, CAH, COR: 5-Year Yield-on-Cost % Comparison
For the Medical Distribution subindustry, Amplifon SpA's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amplifon SpA 5-Year Yield-on-Cost % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Amplifon SpA's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Amplifon SpA's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Amplifon SpA is calculated as
Amplifon SpA (AMFPF) has a 5-Year Yield-on-Cost % of 3.00 as of Jul. 01, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Amplifon SpA and its competitors. This is 335% above median its historical median of 0.69. Over the past decade, Amplifon SpA's 5-Year Yield-on-Cost % has ranged from 0.33 to 3.46. According to the industry distribution chart, Amplifon SpA ranks #38 out of 69 companies in the Medical Distribution industry, placing it in the top 55.1%.
Is Amplifon SpA's 5-Year Yield-on-Cost % too high?
Amplifon SpA's current 5-Year Yield-on-Cost % of 3.00 is 335% above median its 10-year median of 0.69. Over the past 10 years, this metric has ranged from a low of 0.33 to a high of 3.46. The Medical Distribution industry median 5-Year Yield-on-Cost % is 3.33. Amplifon SpA's value of 3.00 is 9.9% below this industry median. Based on the distribution chart, Amplifon SpA ranks #38 out of 69 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Amplifon SpA has a GF Score™ of 71/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Amplifon SpA's 5-Year Yield-on-Cost % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Amplifon SpA ranks #38 out of 69 companies for 5-Year Yield-on-Cost %. This places Amplifon SpA in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.33. Amplifon SpA's value of 3.00 is 9.9% below this benchmark. Historically, Amplifon SpA's own 5-Year Yield-on-Cost % has ranged from 0.33 to 3.46 over the past decade. While the company's 10-year median is 0.69 vs. the industry median of 3.33, Amplifon SpA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Distribution company?
The median 5-Year Yield-on-Cost % among Medical Distribution companies is 3.33, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amplifon SpA's current 5-Year Yield-on-Cost % of 3.00 is 9.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Amplifon SpA and its competitors. For the Medical Distribution industry, the median 5-Year Yield-on-Cost % is 3.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amplifon SpA's current 5-Year Yield-on-Cost % is 3.00, which is 335% above median its own 10-year median of 0.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amplifon SpA stock overvalued right now?
Based on GuruFocus' analysis, Amplifon SpA (AMFPF) is currently considered Possible Value Trap. The stock's GF Value™ is $28.73, compared to a current price of $11.21 — trading 61% below its estimated fair value. The current 5-Year Yield-on-Cost % is 3.00, which is 335% above median its 10-year median of 0.69 and 9.9% below the Medical Distribution industry median of 3.33. Amplifon SpA's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Amplifon SpA (AMFPF), the current 5-Year Yield-on-Cost % is 3.00 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Amplifon SpA (AMFPF) Overvalued in 2026?
Based on GuruFocus' analysis, Amplifon SpA stock appears to be undervalued.
The current stock price of $11.21 is trading 61% below its estimated GF Value™ of $28.73.
GuruFocus considers Amplifon SpA to be Possible Value Trap.
Key valuation signals for AMFPF:
5-Year Yield-on-Cost %: 3.00 (335% above median its 10-year median of 0.69)
GF Value™: $28.73 vs. price of $11.21 (61% below fair value)
Industry Position: 9.9% below the Medical Distribution median (#38 of 69)
No single metric tells the full story. See the AMFPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Amplifon SpA provides customizable hearing solutions and services through a distribution network of network affiliates, corporate shops, franchises, and shop-in-shops. The company operates in three segments based on geography: the Americas; Europe, the Middle East, and Africa; and Asia-Pacific. It generates the majority of its revenue in the EMEA region. It operates under a variety of brands in these regions, including Amplifon, Beter Horen, Maxtone, and Miracle-Ear.
71GF Score
Get the complete analysis for AMFPF
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMFPF has been successfully added to your 